Confounding Variables in Clinical Research: The Hidden Factors Pharmacists Must Consider

As pharmacists, we spend a significant part of our professional lives reading studies and translating data into real clinical decisions. We are trained to ask critical questions: Does the medication work? Is it safe? Is the evidence strong enough to act on?

But behind many published results, there is a silent troublemaker that often goes unnoticed:

They do not announce themselves. They do not come with warning labels. Yet they can completely distort what a study appears to show. Understanding confounding is not optional for pharmacists—it is essential for evidence‑based practice.

🧠 What is a confounding variable (in plain language)?

A confounder is a third factor that is related to:

• The exposure(for example, a drug)
• The outcome(for example, an adverse event)

If it is not properly accounted for, this factor can make a treatment look harmful—or beneficial—when it really isn’t.

Simple analogy:
People who carry umbrellas are more likely to get wet. Umbrellas do not cause wetness— rain is the confounding variable.

📊 Why confounding is especially common in clinical research

Randomized controlled trials reduce confounding through randomization. However, much of modern pharmacotherapy research relies on observational data.

In observational studies:

• Patients are not randomly assigned treatments
• Prescribing decisions reflect patient characteristics
• Sicker patients receive more medications

⏳ Age: the most common (and most dangerous) confounder

Age is one of the strongest confounding variables in clinical research.

Older patients are:

• More likely to take medications
• More likely to experience adverse events
• More likely to have chronic disease

Clinical example:
A study finds that a certain drug is associated with increased mortality. However, the drug is mainly prescribed to older patients. Without proper age adjustment, mortality may be wrongly attributed to the medication instead of age.

🏥 Comorbidities: when disease severity distorts drug effects

Patients with multiple comorbidities:

• Receive more aggressive therapy
• Experience more clinical events regardless of treatment

This leads to confounding by indication —one of the most important biases in pharmacotherapy research.

Classic pharmacist‑level example:
Patients prescribed strong anticoagulants show higher bleeding rates. Is the drug unsafe, or are these patients already at high baseline bleeding risk?

This type of confounding is well recognized and difficult to fully eliminate—even with advanced statistical methods.

🚬 Lifestyle confounders: the unmeasured problem

Lifestyle factors strongly influence outcomes but are notoriously hard to measure accurately:

• Smoking
• Diet
• Physical activity
• Alcohol consumption

Large healthcare databases often lack detailed lifestyle information, leaving behind residual confounding even after adjustment.

🧮 How do researchers try to fix confounding?

The main approach is multivariable adjustment.

What is multivariable adjustment?

It is a statistical method used to hold confounding variables constant so the effect of the exposure of interest can be better isolated.

Instead of comparing outcomes between “drug users” and “non‑users,” researchers adjust for differences in:

• Age
• Sex
• Comorbidities
• Other relevant clinical variables

📝 Multivariable adjustment explained step by step

Study question:
Does Drug A increase the risk of kidney injury?

Step 1: Identify potential confounders

Researchers identify variables that influence both prescribing decisions and kidney injury risk, such as age, diabetes, hypertension, and baseline kidney function.

Clinical judgment is critical here—choosing appropriate variables matters more than choosing many variables.

Step 2: Build a statistical model

The model includes kidney injury as the outcome, Drug A as the exposure, and confounders as additional variables.

Step 3: Interpret the adjusted result

The study reports an adjusted odds ratio, risk ratio, or hazard ratio.

⚠️ Important limitations of multivariable adjustment

• You cannot adjust for what was not measured.
• Overadjustment can create new bias.
• Residual confounding always remains.

This is why observational studies show associations, not proof of causation.

💊 Why this matters for pharmacists

Misunderstanding confounding can lead to:

• Overestimating drug harm
• Underestimating drug benefit
• Inappropriate deprescribing
• Misleading patient counseling

Pharmacists serve as translators of evidence—especially when patients react to headlines or study summaries.

Understanding confounding allows pharmacists to ask better clinical questions:

• Who were the patients?
• Why was the drug prescribed?
• What factors were not measured?

✅ Quick Knowledge Check

Key takeaway for pharmacists:
Confounding does not make a study useless—but it demands humility in interpretation. Mastering this concept protects patients from misinterpreted evidence and strengthens evidence‑based practice.